Hybrid nanotube stamp system for cancer treatment (IMAGE)

Waseda University

Hybrid nanotube stamp system for cancer treatment

Caption

The HyNT stamp system effectively delivers LOx and UQ to 1.8 × 107 adhesive cells with a viability of 97.1%. This system through the delivery of LOx enzyme can effectively eradicate cancerous cells with minimal impact on healthy cells.

Credit

Takeo Miyake from Waseda University

Usage Restrictions

Cannot be reused without permission

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.